Aimin Xu
Impact in
- Physiology top 0.05%
- Adipose Tissue and Metabolism
- Epidemiology top 0.02%
- Adipokines, Inflammation, and Metabolic Diseases
- Liver Disease Diagnosis and Treatment
Papers in
-
- Fibroblast Growth Factor Research 55
- Peroxisome Proliferator-Activated Receptors 38
- Kruppel-like factors research 30
- Metabolism, Diabetes, and Cancer 26
- Epigenetics and DNA Methylation 25
- Epidemiology 162
- Adipokines, Inflammation, and Metabolic Diseases 132
- Liver Disease Diagnosis and Treatment 27
- Co-authors
- Karen S.L. Lam (149 shared papers)Yu Wang (118 shared papers)Garth J. S. Cooper (21 shared papers)Lance Yi Xu (7 shared papers)Paul M. Vanhoutte (33 shared papers)Ruby L.C. Hoo (34 shared papers)Hussila Keshaw (2 shared papers)Jialiang Zhang (18 shared papers)
In The Last Decade
Aimin Xu
513 papers receiving 33.6k citations
Aimin Xu's Hit Papers
Peers
Comparison fields: 5 of 169
- Physiology 8.6k
- Epidemiology 10.8k
- Endocrine and Autonomic Systems 1.6k
- Molecular Biology 13.5k
- Cardiology and Cardiovascular Medicine 3.8k
Countries citing papers authored by Aimin Xu
This map shows the geographic impact of Aimin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimin Xu more than expected).
Fields of papers citing papers by Aimin Xu
This network shows the impact of papers produced by Aimin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimin Xu. The network helps show where Aimin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 530 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice Hit paper breakdown → | 2003 | 1026 |
| 2 | The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice Hit paper breakdown → | 2003 | 946 |
| 3 | Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans Hit paper breakdown → | 2008 | 770 |
| 4 | Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice Hit paper breakdown → | 2016 | 606 |
| 5 | Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice Hit paper breakdown → | 2013 | 575 |
| 6 | 2006 | 490 | |
| 7 | 2006 | 479 | |
| 8 | The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic Hit paper breakdown → | 2020 | 433 |
| 9 | Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Hit paper breakdown → | 2022 | 392 |
| 10 | Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation Hit paper breakdown → | 2019 | 382 |
| 11 | 2005 | 361 | |
| 12 | 2012 | 342 | |
| 13 | 2008 | 331 | |
| 14 | 2010 | 325 | |
| 15 | 2005 | 319 | |
| 16 | 2016 | 309 | |
| 17 | 2002 | 302 | |
| 18 | 2004 | 295 | |
| 19 | 2019 | 294 | |
| 20 | 2015 | 285 |
About Aimin Xu
Aimin Xu is a scholar working on Molecular Biology, Epidemiology, Physiology, Cardiology and Cardiovascular Medicine and Surgery, having authored 530 papers that have together received 34.1k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (132 papers), Adipose Tissue and Metabolism (94 papers), Fibroblast Growth Factor Research (55 papers), Peroxisome Proliferator-Activated Receptors (38 papers), Kruppel-like factors research (30 papers), Liver Disease Diagnosis and Treatment (27 papers), Metabolism, Diabetes, and Cancer (26 papers) and Epigenetics and DNA Methylation (25 papers). The work is most often cited by research in Physiology (8.6k citations), Epidemiology (10.8k citations), Endocrine and Autonomic Systems (1.6k citations), Molecular Biology (13.5k citations) and Cardiology and Cardiovascular Medicine (3.8k citations). Aimin Xu has collaborated with scholars based in Hong Kong, China and Czechia. Frequent co-authors include Karen S.L. Lam, Yu Wang, Garth J. S. Cooper, Lance Yi Xu, Paul M. Vanhoutte, Ruby L.C. Hoo, Hussila Keshaw, Jialiang Zhang, Kenneth K.Y. Cheng and Annette W.K. Tso. Their work appears in journals such as Diabetes, PLoS ONE, Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.